Literature DB >> 6267914

Cyclic nucleotides, possible intracellular mediators of macrophage activation and secretory processes.

S J Foster.   

Abstract

Macrophages from various sources can be stimulated by a variety of substances to secrete a range of inflammatory mediators and degradative enzymes. The mechanisms involved in the activation and secretory processes are unknown, However, recent evidence suggests that cyclic AMP may play a role in the regulation of neutral protease secretion. Thus, it has been shown that agents known to increase intracellular cyclic AMP levels (cyclic AMP analogues, phosphodiesterase inhibitors, prostaglandin E1 and E2, catecholamines, cholera toxin and, indirectly, glucocorticosteroids) inhibit the secretion of the neutral protease plasminogen activator. It is speculated that macrophage activation may also initiated by changes in the steady-state levels of cyclic nucleotides. A decrease in intracellular cyclic AMP and/or an increase in cyclic GMP levels would favour secretion. It is possible that these changes could be brought about by the action of various stimuli to modify the capacity of the macrophage to synthetize or degrade cyclic nucleotides.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6267914     DOI: 10.1007/bf02024165

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

1.  Alteration of hormone-stimulated cyclic AMP synthesis in guinea pig peritoneal macrophages.

Authors:  E Remold-O'Donnell; H R Alpert
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

2.  Effects of steroids on the regulation of the levels of cyclic AMP in human lymphocytes.

Authors:  T P Lee; C E Reed
Journal:  Biochem Biophys Res Commun       Date:  1977-10-10       Impact factor: 3.575

3.  Glucocorticoids increase the responsiveness of cells in culture to prostaglandin E1.

Authors:  S J Foster; J P Perkins
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage line.

Authors:  Z Werb; R Foley; A Munck
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

5.  Modulation of plasminogen activator secretion by activated macrophages: influence of serum factors and correlation with tumoricidal potential.

Authors:  H A Chapman; Z Vavrin; J B Hibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  The enhancement of macrophage adenylate cyclase by products of activated lymphocytes.

Authors:  E Remold-O'Donnell; H G Remold
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

7.  Cyclic nucleotides and modulation of effector systems of inflammation.

Authors:  M Kaliner; K F Austen
Journal:  Biochem Pharmacol       Date:  1974-02-15       Impact factor: 5.858

Review 8.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

9.  Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids.

Authors:  F P Nijkamp; R J Flower; S Moncada; J R Vane
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

10.  Cyclic adenosine 3':5'-monophosphate-stimulated phosphorylation of isolated neurotubule subunits.

Authors:  D B Goodman; H Rasmussen; F DiBella; C E Guthrow
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

View more
  1 in total

1.  Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.

Authors:  J Silvola; M Kangasaho; O Tokola; H Vapaatalo
Journal:  Agents Actions       Date:  1982-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.